D.A. Davidson & CO. Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

D.A. Davidson & CO. boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 10.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,295 shares of the biotechnology company’s stock after purchasing an additional 797 shares during the period. D.A. Davidson & CO.’s holdings in Axon Enterprise were worth $1,651,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of AXON. Capital International Investors lifted its position in shares of Axon Enterprise by 605.2% during the first quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock worth $366,449,000 after purchasing an additional 2,283,343 shares during the last quarter. Sands Capital Management LLC lifted its position in shares of Axon Enterprise by 101.6% during the second quarter. Sands Capital Management LLC now owns 1,993,126 shares of the biotechnology company’s stock worth $388,899,000 after purchasing an additional 1,004,556 shares during the last quarter. BlackRock Inc. lifted its holdings in Axon Enterprise by 11.7% in the first quarter. BlackRock Inc. now owns 8,329,479 shares of the biotechnology company’s stock worth $1,872,883,000 after acquiring an additional 870,481 shares during the last quarter. Norges Bank bought a new position in Axon Enterprise in the fourth quarter worth about $102,920,000. Finally, Geode Capital Management LLC lifted its holdings in Axon Enterprise by 57.3% in the second quarter. Geode Capital Management LLC now owns 1,583,100 shares of the biotechnology company’s stock worth $308,281,000 after acquiring an additional 576,420 shares during the last quarter. Institutional investors own 76.52% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $270.98 on Friday. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $271.39. The company has a debt-to-equity ratio of 0.44, a current ratio of 3.15 and a quick ratio of 2.78. The firm has a market capitalization of $20.30 billion, a PE ratio of 138.96 and a beta of 0.90. The company’s 50 day simple moving average is $252.03 and its 200 day simple moving average is $222.86.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on AXON shares. TheStreet raised shares of Axon Enterprise from a “c” rating to a “b” rating in a report on Tuesday, November 7th. Raymond James raised their target price on shares of Axon Enterprise from $223.00 to $233.00 and gave the stock an “outperform” rating in a report on Wednesday, November 8th. JMP Securities raised their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 6th. Needham & Company LLC reissued a “buy” rating and issued a $240.00 target price on shares of Axon Enterprise in a report on Friday, February 2nd. Finally, Barclays raised their target price on shares of Axon Enterprise from $247.00 to $296.00 and gave the stock an “overweight” rating in a report on Tuesday, January 2nd. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $255.36.

Get Our Latest Stock Analysis on AXON

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 260 shares of the firm’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $230.38, for a total transaction of $59,898.80. Following the transaction, the president now owns 356,229 shares in the company, valued at $82,068,037.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, President Joshua Isner sold 260 shares of the firm’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $230.38, for a total transaction of $59,898.80. Following the transaction, the president now owns 356,229 shares in the company, valued at $82,068,037.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,796 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $253.46, for a total transaction of $455,214.16. Following the completion of the transaction, the insider now owns 228,805 shares in the company, valued at approximately $57,992,915.30. The disclosure for this sale can be found here. Insiders have sold 44,176 shares of company stock worth $11,017,910 over the last quarter. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.